Chemed CHE Deferred Foreign Income Tax Expense Benefit
Deferred Foreign Income Tax Expense Benefit at other companies
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept us-gaap:DeferredForeignIncomeTaxExpenseBenefit.
The official record: Chemed’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Chemed's deferred foreign income tax expense benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Chemed's deferred foreign income tax expense benefit?
- Chemed (CHE) reported deferred foreign income tax expense benefit of -$750 in Q4 2025.
- How has Chemed's deferred foreign income tax expense benefit changed year-over-year?
- Chemed's deferred foreign income tax expense benefit decreased by 250.0% year-over-year, from $500 to -$750.
- What is the long-term trend for Chemed's deferred foreign income tax expense benefit?
- Over 4 years (2021 to 2025), Chemed's deferred foreign income tax expense benefit has grown at a -48.3% compound annual growth rate (CAGR), from $42K to -$3K.
- What does deferred foreign income tax expense benefit mean?
- Represents the net change in deferred income tax assets and liabilities specifically related to foreign jurisdictions. This captures the future tax impact of temporary differences arising from international operations. It is used to evaluate the long-term tax implications of the company's global asset and liability structure.